asset coin Top See results about

Increase the countercyclical adjustment of macro policies. A series of reform measures will be introduced next year. From the national development and reform work conference held by the National Development and Reform Commission, we learned that in order to fully implement the spirit of the Central Economic Work Conference, we will increase the countercyclical adjustment of macro policies next year, and solidly promote economic stability, structural improvement and development trend. The relevant person in charge of the National Development and Reform Commission said that a more active and promising macro policy will be implemented next year to enhance the consistency of macro policy orientation.Morgan Stanley raised Broadcom target price from $180.00 to $233.00.Zhuhai Zhongfu: The controlling shareholder and actual controller intend to change. Zhuhai Zhongfu announced that the company intends to issue A shares to a specific target, with a planned number of 321,224,764 shares, and the total amount of funds raised is 822 million yuan. Xunzhen Investment intends to subscribe for the shares issued by the company in cash. After the completion of this issuance, the controlling shareholder and actual controller of the company will change. Before this issuance, the controlling shareholder of the company was Xinsi Road, and there was no actual controller. After this issuance, the controlling shareholder will be changed to Xunzhen Investment, and the actual controller will be changed to Yu Timing. The issuance still needs to be approved by the company's shareholders' meeting, examined and approved by Shenzhen Stock Exchange and approved by China Securities Regulatory Commission.

The NASDAQ 100 index rose to about 1.2%, and Broadcom, a constituent stock, rose by more than 21%, Maiwell Technology rose by 9.8%, ARM rose by 4.5%, Micron Technology rose by 4.1%, Ram Research rose by 1.8%, ASML ADR rose by 1.5%, and Grail, a biotechnology company, rose by 1.8%.Jiaying Pharmaceutical Co., Ltd.: It plans to buy back 7 million to 13.5 million shares. Jiaying Pharmaceutical announced that it plans to use its own funds to buy back some issued RMB common shares (A shares) by centralized bidding for the implementation of employee stock ownership plan or equity incentive. The price of repurchased shares is not higher than 9.80 yuan/share (inclusive), and the number of shares to be repurchased is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; And no more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. The repurchase period is within 12 months from the date when the company's board of directors deliberated and approved the share repurchase plan.Destiny Tech100(DXYZ), a closed-end fund associated with SpaceX, a space exploration company owned by Musk, once fell more than 10%, and the refresh date was as low as $65.28. On December 11th, the price of the fund rose to $77.35, which was 567.38% higher than the closing price on November 5th (the polling day of the US election).

Nasdaq hit a record high in intraday trading, up 0.8%.The foreign trade export liner of western land and sea new channel lighters made its maiden voyage. On December 13th, with the container liner Haifeng Guangxi carrying 32 tons of lighters from Shaodong enterprises in Hunan slowly leaving Qinzhou Automation Container Terminal in beibu gulf port, the foreign trade export train of (Hunan/Guizhou-Beibu Gulf Port-Jakarta) western land and sea new channel lighters made its maiden voyage successfully. (Zhongxin. com)The Dow Jones Industrial Average is now at 43,917.68 points, up 3.56 points.